1Institute for Drug Discovery Research, Yamanouchi Pharmaceutical, Tsukuba, Ibaraki, Japan. abe_m@yamanouchi.co.jp
You might also read
Articles linked to this work by shared authors, journal, and citation graph.
Antibodies targeting human c-Mpl (thrombopoietin receptor) stimulate megakaryocyte proliferation. Bivalent antibody binding to c-Mpl receptors is crucial for this cell growth, similar to thrombopoietin (TPO) action.
Area of Science:
Background:
Purpose of the Study:
Main Methods:
Main Results:
Conclusions: